Consolidation radiotherapy may improve outcomes in people with Hodgkin's disease achieving complete remission after combination chemotherapy: Abstracted from: Laskar S, Gupta T, Vimal S et al. Consolidation radiation after complete remission in Hodgkin's disease following six cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy: is there a need? J Clin Oncol 2004;22:62–68.

References 

1. Meyer R, Gospodarowicz M, Connors JM, et al.  A randomized phase III comparison of single-modality ABVD with a strategy that includes radiation therapy in patients with early-stage Hodgkin's disease. The HD-6 trial of the National Cancer Institute of Canada Clinical Trials Group. Blood. 2003;102:26a
2. Nachman JB, Sposto R, Herzog P, et al.  Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy. J. Clin. Oncol. 2002;20:3765–3771
   • MEDLINE
   • CrossRef
3. Aleman BM, Raemaekers JM, Tirelli U, et al.  Involved-field radiotherapy for advanced Hodgkin's lymphoma. N. Engl. J. Med. 2003;348:2396–2406
   • CrossRef
4. Loeffler M, Brosteanu O, Hasenclever D, et al.  Meta-analysis of chemotherapy versus combined modality treatment trials in Hodgkin's disease. International Database on Hodgkin's Disease Overview Study Group. J. Clin. Oncol. 1998;16:818–829
   • MEDLINE
5. Prosnitz LR. Consolidation radiotherapy in the treatment of advanced Hodgkin's disease: is it dead?. Int. J. Radiat. Oncol. Biol. Phys. 2003;56:605–608
   • Full Text
   • Full-Text PDF (48 KB)
   • CrossRef